Exelixis raises $118.3 million

Comparative genomics company EXEL raised $118.3 million in an IPO of 9.1 million shares at $13 underwritten by Goldman Sachs; CS First Boston; and SG Cowen. On March 7, EXEL filed to raise up to $100 ...